Author:
Orfão Nathalia Halax,Andrade Rubia Laine de Paula,Ruffino-Netto Antônio,da Silva Leila Wiedmann Florentino,Villa Tereza Cristina Scatena,Seifert Marva Lynn,Zilly Adriana,Arcoverde Marcos Augusto Moraes,Hoare Ismael,Izurieta Ricardo,da Silva-Sobrinho Reinaldo Antônio
Abstract
Abstract
Background
To analyze the influence of the COVID-19 pandemic on the process of diagnosis and monitoring of drug-resistant pulmonary tuberculosis (TB) cases reported in the state of Paraná, Brazil, from 2015 to 2020.
Methods
Ecological study with quantitative approach. This study was based on diagnosed cases of pulmonary TB reported in the Notifiable Disease Information System in residents of Paraná; as well as through the number of confirmed cases of COVID-19 in the state epidemiological bulletin for the year 2020. The study data were analyzed using descriptive statistics.
Results
It was found that, although the number of reported pulmonary TB cases (drug-resistant and general) increased between 2015 and 2019, there was a drop in notification in 2020, the first year of the COVID-19 pandemic. The notification of TB cases was also influenced monthly during the year according to the increase in the number of COVID-19 cases. For cases of drug-resistant pulmonary TB, the provision of diagnostic tests and Directly Observed Treatment decreased by more than half in 2020, especially when compared to 2019.
Conclusions
In view of these findings, the influence of COVID-19 on the diagnosis and monitoring of drug-resistant and general pulmonary TB cases is evident, showing that the pandemic has compromised the advances of recent decades in achieving the goals established for its eradication by 2035.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. World Health Organization (WHO). Global tuberculosis Report 2021. Geneva: WHO; 2021.
2. Kendall EA, Fofana MO, Dowdy DW. Carga da multirresistência transmitida em epidemias de tuberculose: uma análise de modelagem de transmissão. Lancet Respir Med. 2015;3(12):963–72.
3. Brasil. Ministério da Saúde. Manual de Recomendações para o Controle da tuberculose no Brasil. Brasília, 2019.
4. Bartholomay P, Pinheiro RS, Johansen FDC, Oliveira SB, Rocha MS, Pelissari DM, Araújo WN. Lacunas na vigilância da tuberculose drogarresistente: relacionando sistemas de informação do Brasil. Cad Saúde Pública. 2020;36(4):e00082219.
5. Gniech AL, Gniech NR, Polese TR, D’Agostini FM, Fernandes LS. Tuberculose: perfil epidemiológico no estado de Santa Catarina, fatores de risco e resistência microbiana. Revista Multidisciplinar em Saúde. 2021;2(1):1.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献